-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on CareTrust REIT, Lowers Price Target to $44

Benzinga·10/13/2026 21:10:19
Listen to the news
UBS analyst Michael Goldsmith maintains CareTrust REIT (NYSE:CTRE) with a Buy and lowers the price target from $48 to $44.